Forte Biosciences Inc.

Forte Biosciences Inc is a clinical-stage biopharmaceutical company, focused on dermatology. The company is developing a live biotherapeutic, FB-401, for the treatment of inflammatory skin diseases. FB-401 has completed Phase 1/2a testing in adult and pediatric patients with atopic dermatitis. It plans to advance FB-401 into a randomized Phase 2 clinical trial.

Investing News NetworkYour trusted source for investing success

13 Canadian Crypto ETFs (Updated 2024)

Leigh Goehring: Gold's "Massive Bull Market" Just Starting; Uranium and Copper Outlook

When is the Starlink IPO Date and Can You Invest? (Updated 2024)

10 Top Oil-producing Countries (Updated 2024)

Could the Silver Price Really Hit $100 per Ounce? (Updated 2024)

How Would a New BRICS Currency Affect the US Dollar? (Updated 2024)

Uranium Stocks: 5 Biggest Companies in 2024

Top 4 Largest Lithium Reserves by Country (Updated 2024)

How Could Trump's US Election Win Affect the Gold Price?

McDermitt PFS Demonstrates Multi-Decade Competitive Source of US Lithium Carbonate

OSISKO METALS EXPANDS LEADERSHIP TEAM AND ANNOUNCES C$100 MILLION BOUGHT DEAL FINANCING

Osisko Metals Announces Significant Increase in Mineral Resources at Gaspé Copper

Silver47 Drills 2.48m of 14.95 g/t Gold, 249.50 g/t Silver, 21.97% Zinc, 7.03% Lead, 0.42% Copper at Its Red Mountain Project, Alaska

SAGA Metals Announces Assay Results from North Wind Iron Ore Project

Sirona Biochem Announces Publication of Groundbreaking Study on TFC-1326 Compound in the Journal of Cosmetic Dermatology

Silver47 Exploration

Purpose Bitcoin ETF

Osisko Metals: Leading the Charge in Base Metal Investments

Syntheia

2024 Gold Outlook Report

2024 Lithium Market Outlook

2024 AI Market Outlook Report

Silver Price Forecast - What Happened And Where Do We Go From Here?

Forte Biosciences Inc.

Stem Cell Stocks: 10 Biggest NASDAQ Companies

Top 4 Canadian Biotech Stocks of 2024

Interactive Chart